These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25381201)

  • 1. Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinoma.
    Guzman G; Chennuri R; Chan A; Rea B; Quintana A; Patel R; Xu PZ; Xie H; Hay N
    Dig Dis Sci; 2015 Feb; 60(2):420-6. PubMed ID: 25381201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.
    Peng SY; Lai PL; Pan HW; Hsiao LP; Hsu HC
    Oncol Rep; 2008 Apr; 19(4):1045-53. PubMed ID: 18357395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
    Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma.
    Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L
    Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological features of cirrhosis with hepatitis C virus for prediction of hepatocellular carcinoma development; a prospective study.
    Makino Y; Shiraki K; Sugimoto K; Ito T; Yamanaka T; Fujikawa K; Takase K; Nakano T
    Anticancer Res; 2000; 20(5C):3709-15. PubMed ID: 11268443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of alpha methylacyl-coenzyme A racemase in differentiating hepatocellular carcinoma from dysplastic and nondysplastic liver cell lesions.
    Helal Tel A; Radwan NA; Abdel Kader Z; Helmy NA; Hammad SY
    Ann Diagn Pathol; 2012 Oct; 16(5):330-4. PubMed ID: 22542076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.
    Ahn KJ; Hwang HS; Park JH; Bang SH; Kang WJ; Yun M; Lee JD
    J Nucl Med; 2009 Sep; 50(9):1525-32. PubMed ID: 19690031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
    Stefano JT; de Oliveira CP; Corrêa-Giannella ML; Soares IC; Kubrusly MS; Bellodi-Privato M; de Mello ES; de Lima VM; Carrilho FJ; Alves VA
    Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
    Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
    Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor α immunoreactivity. A study in hepatocellular carcinoma and in non-neoplastic liver tissue.
    Pannain VL; Morais JR; Damasceno-Ribeiro O; Avancini-Alves V
    Ann Hepatol; 2012; 11(4):495-9. PubMed ID: 22700631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three types of liver cell dysplasia (LCD) in small cirrhotic nodules are distinguishable by karyometry and PCNA labelling, and their features resemble distinct grades of hepatocellular carcinoma.
    Zhao M; Zhang NX; Du ZY; Laissue JA; Zimmermann A
    Histol Histopathol; 1994 Jan; 9(1):73-83. PubMed ID: 7911690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
    Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
    Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis.
    Lefkowitch JH; Apfelbaum TF
    Arch Pathol Lab Med; 1987 Feb; 111(2):170-3. PubMed ID: 3028314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers.
    Vasuri F; Fittipaldi S; Giunchi F; Monica M; Ravaioli M; Degiovanni A; Bonora S; Golfieri R; Bolondi L; Grigioni WF; Pasquinelli G; D'Errico-Grigioni A
    J Clin Pathol; 2016 Feb; 69(2):102-8. PubMed ID: 26243063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver cell dysplasia in cirrhosis. A serologic and immunohistochemical study.
    Roncalli M; Borzio M; De Biagi G; Ferrari AR; Macchi R; Tombesi VM; Servida E
    Cancer; 1986 Apr; 57(8):1515-21. PubMed ID: 2418942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.